These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18342566)

  • 21. Notch increases the shedding of HB-EGF by ADAM12 to potentiate invadopodia formation in hypoxia.
    Díaz B; Yuen A; Iizuka S; Higashiyama S; Courtneidge SA
    J Cell Biol; 2013 Apr; 201(2):279-92. PubMed ID: 23589494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-Like Growth Factor-I Increases Laminin, Integrin Subunits and Metalloprotease ADAM12 in Mouse Myoblasts.
    Grzelkowska-Kowalczyk K; Grabiec K; Tokarska J; Gajewska M; Błaszczyk M; Milewska M
    Folia Biol (Krakow); 2015; 63(4):241-7. PubMed ID: 26975138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition.
    Ruff M; Leyme A; Le Cann F; Bonnier D; Le Seyec J; Chesnel F; Fattet L; Rimokh R; Baffet G; Théret N
    PLoS One; 2015; 10(9):e0139179. PubMed ID: 26407179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
    Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
    Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A disintegrin and metalloprotease 12 (ADAM12) is a prognostic factor in resected pathological stage I lung adenocarcinoma.
    Mino N; Miyahara R; Nakayama E; Takahashi T; Takahashi A; Iwakiri S; Sonobe M; Okubo K; Hirata T; Sehara A; Date H
    J Surg Oncol; 2009 Sep; 100(3):267-72. PubMed ID: 19544357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogen-activated protein kinase (MAPK) regulates leukotriene D4-induced HB-EGF and ADAM12 expression in human airway smooth muscle cells.
    Kumasawa F; Hashimoto S; Mizumura K; Takeshita I; Onose A; Jibiki I; Maruoka S; Gon Y; Kobayashi T; Takahashi N
    Asian Pac J Allergy Immunol; 2013 Mar; 31(1):58-66. PubMed ID: 23517395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM12 induces EMT and promotes cell migration, invasion and proliferation in pituitary adenomas via EGFR/ERK signaling pathway.
    Wang J; Zhang Z; Li R; Mao F; Sun W; Chen J; Zhang H; Bartsch JW; Shu K; Lei T
    Biomed Pharmacother; 2018 Jan; 97():1066-1077. PubMed ID: 29136943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extravillous trophoblast-associated ADAM12 exerts pro-invasive properties, including induction of integrin beta 1-mediated cellular spreading.
    Biadasiewicz K; Fock V; Dekan S; Proestling K; Velicky P; Haider S; Knöfler M; Fröhlich C; Pollheimer J
    Biol Reprod; 2014 May; 90(5):101. PubMed ID: 24695627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
    Higashiyama S
    Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function.
    Kawaguchi N; Sundberg C; Kveiborg M; Moghadaszadeh B; Asmar M; Dietrich N; Thodeti CK; Nielsen FC; Möller P; Mercurio AM; Albrechtsen R; Wewer UM
    J Cell Sci; 2003 Oct; 116(Pt 19):3893-904. PubMed ID: 12915587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A disintegrin and metalloprotease-12 is type I myofiber specific in Bos taurus and Bos indicus cattle.
    Coles CA; Wadeson J; Knight MI; Cafe LM; Johns WH; White JD; Greenwood PL; McDonagh MB
    J Anim Sci; 2014 Apr; 92(4):1473-83. PubMed ID: 24663211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
    Duhachek-Muggy S; Zolkiewska A
    BMC Cancer; 2015 Mar; 15():93. PubMed ID: 25886595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cooperation of the metalloprotease, disintegrin, and cysteine-rich domains of ADAM12 during inhibition of myogenic differentiation.
    Yi H; Gruszczynska-Biegala J; Wood D; Zhao Z; Zolkiewska A
    J Biol Chem; 2005 Jun; 280(25):23475-83. PubMed ID: 15849365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAM12-directed ectodomain shedding of E-cadherin potentiates trophoblast fusion.
    Aghababaei M; Hogg K; Perdu S; Robinson WP; Beristain AG
    Cell Death Differ; 2015 Dec; 22(12):1970-84. PubMed ID: 25909890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A substrate-optimized electrophoretic mobility shift assay for ADAM12.
    Kotzsch A; Skovgaard T; Buus U; Andersen S; Devkota K; Berthelsen J
    Anal Biochem; 2014 May; 452():34-42. PubMed ID: 24534253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular profiling of ADAM12 gene in breast cancers.
    Nariţa D; Anghel A; Seclaman E; Ilina R; Cireap N; Ursoniu S
    Rom J Morphol Embryol; 2010; 51(4):669-76. PubMed ID: 21103624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADAM12 redistributes and activates MMP-14, resulting in gelatin degradation, reduced apoptosis and increased tumor growth.
    Albrechtsen R; Kveiborg M; Stautz D; Vikeså J; Noer JB; Kotzsh A; Nielsen FC; Wewer UM; Fröhlich C
    J Cell Sci; 2013 Oct; 126(Pt 20):4707-20. PubMed ID: 24006261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of ADAM12, a marker of skeletal muscle regeneration, to the muscle-specific actin-binding protein, alpha -actinin-2, is required for myoblast fusion.
    Galliano MF; Huet C; Frygelius J; Polgren A; Wewer UM; Engvall E
    J Biol Chem; 2000 May; 275(18):13933-9. PubMed ID: 10788519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
    Higashiyama S; Nanba D
    Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.